Literature DB >> 28969115

Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.

Suchismita Panda1, Anuva Mishra2, Manoranjan Jena3, Sashi Bhusan Rout4, Srikrushna Mohapatra5.   

Abstract

INTRODUCTION: Anaemia is one of the common complications associated with Chronic Kidney Disease (CKD) responsible for the increase in the morbidity and mortality in such patients. Several factors have been attributed to cause renal anaemia, amongst which hyperparathyroidism is one of the less recognised reasons. Most studies have been conducted in this regard in CKD patients undergoing haemodialysis. The level of PTH in early stages of chronic kidney disease has not been much studied. The excess amount of Parathyroid Hormone (PTH) secondary to CKD has been suggested to be a causative factor for anaemia. AIM: To evaluate the serum PTH level in CKD patients before haemodialysis and to study the association of the haemoglobin status with the parathyroid hormone.
MATERIALS AND METHODS: Forty CKD patients above 18 years of age before haemodialysis and 25 age and sex matched healthy controls were included in the study. Routine biochemical and haematological parameters such as Routine Blood Sugar (RBS), urea, creatinine, Na+, K+, Ca2+, PTH and Hb% were perfomed. Red cell osmotic fragility was measured by serial dilutions of whole blood with varying concentrations of sodium chloride ranging from 0.1% to 0.9%.
RESULTS: The study revealed a significant fall in Hb%, along with a rise in Median Osmotic Fragility (MOF) and PTH in the CKD patients when compared to the control group. Linear regression of PTH with Hb% revealed significant negative association between both the parameters with a R2 value of 0.677. Multilinear regression analysis of MOF and other independent variables such as Hb%, Na+, K+, Ca2+, urea, PTH and creatinine highlighted the variance of MOF by 72%, maximal variance contributed by PTH. Receiver Operating Curve (ROC) analysis revealed an area under the curve of 0.980 with a sensitivity of 100% and specificity of 87% in detecting osmotic fragility at a cut off value of PTH ≥100 pg/ml.
CONCLUSION: The underlying cause of anaemia should be identified early in the CKD patients before haemodialysis. Secondary hyperparathyroidism should be ruled out as a causative factor of anaemia to slow down the progression of the disease process.

Entities:  

Keywords:  Anaemia; Hyperparathyroidism; Osmotic fragility

Year:  2017        PMID: 28969115      PMCID: PMC5620755          DOI: 10.7860/JCDR/2017/27344.10514

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS.

Authors:  A K Parpart; P B Lorenz; E R Parpart; J R Gregg; A M Chase
Journal:  J Clin Invest       Date:  1947-07       Impact factor: 14.808

2.  Phosphate and FGF23 in early CKD: on how to tackle an invisible foe.

Authors:  Markus Ketteler; Arndt T Petermann
Journal:  Nephrol Dial Transplant       Date:  2011-08       Impact factor: 5.992

Review 3.  Hyperparathyroidism and anemia in renal failure.

Authors:  M Gallieni; C Corsi; D Brancaccio
Journal:  Am J Nephrol       Date:  2000 Mar-Apr       Impact factor: 3.754

4.  Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia.

Authors:  G Coen; S Calabria; G Bellinghieri; F Pecchini; F Conte; M G Chiappini; M Ferrannini; C Lagona; A Mallamace; M Manni; M DiLuca; D Sardella; F Taggi
Journal:  Nephron       Date:  2001-06       Impact factor: 2.847

5.  Relation between echinocytosis and erythrocyte calcium content in hemodialyzed uremic patients.

Authors:  B Agroyannis; I Kopelias; C Fourtounas; A Paraskevopoulos; H Tzanatos; A Dalamangas; E Mallas
Journal:  Artif Organs       Date:  2001-06       Impact factor: 3.094

Review 6.  Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.

Authors:  Diego Brancaccio; Mario Cozzolino; Maurizio Gallieni
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

7.  Relation between Serum Intact Parathyroid Hormone Level and Hematocrit in Chronic Kidney Disease Patients.

Authors:  L P Adhikary; A Pokhrel; S K Yadava; D Khadka; R Thakur
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2015 Jul-Sep

Review 8.  Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.

Authors:  Tilman B Drüeke; Kai-Uwe Eckardt
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

9.  The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

Authors:  Ian H De Boer; Irina Gorodetskaya; Belinda Young; Chi-Yuan Hsu; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

10.  Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.

Authors:  Sanjay K Bhadada; Anil Bhansali; Jasmina Ahluwalia; G V Chanukya; Arunanshu Behera; Pinaki Dutta
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-22       Impact factor: 3.478

View more
  1 in total

1.  Association between Serum Magnesium and Hemoglobin in Patients with Primary Hyperparathyroidism.

Authors:  Na Ding; Tao Guo; Shu-Ying Liu; Qin-Yi Wang; Xiao-Li Qu; Yong-Fang Li; Yang-Na Ou; Yan-Yi Yang; Zhi-Feng Sheng
Journal:  Int J Endocrinol       Date:  2021-11-27       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.